Skip to main content
Blank Spacer
Help Site: C
Pharmacy Logo
This page is for pharmacy and health care providers, pharmaceutical company government affairs representatives, and others who have an interest in pharmacy-specific program information of the Connecticut Medical Assistance Program of DSS. Here you will find information and links to pharmacy program information.

Pharmacy Program Publications
  • CADAP and CIPA Programs: The State of Connecticut CADAP and CIPA Services are being administered by the Connecticut Department of Public Health beginning November 1, 2018. All Applications and information about the Connecticut CADAP and CIPA programs can be found on line at this Web location:
  • or email with specific questions.


    Preferred Drug List Information

    The Connecticut Medicaid Preferred Drug Lists (PDL) are a listing of prescription products recommended by the Pharmaceutical and Therapeutics Committee as efficacious, safe, and cost effective choices when prescribing for Medicaid patients. Most FDA approved drugs that are not listed are available, with prior authorization by calling Gainwell Technologies toll-free at 1-866-409-8386.

    Drug classes will be added as the Pharmaceutical & Therapeutics Committee review additional classes. The PDLs are not an all-inclusive list of covered Medicaid drugs. Approximately 100 classes of drugs are on the PDL at any time and represent a portion of the total number of classes of drugs available to clients.

    HIV medications are excluded from the PDL legislation and will always be preferred drugs and not require a Prior Authorization for PDL.

    Current Medicaid Preferred Drug List

    Alphabetized Preferred Drug List 

    Preferred Drug List Changes 

    Previous Preferred Drug Lists

    Diabetic Supplies Preferred Product List

    Previous Diabetic Supplies Preferred Product List

    Pharmaceutical and Therapeutics Committee
    The purpose of the Medicaid Pharmaceutical & Therapeutics Committee is to develop and implement a voluntary Medicaid preferred prescribed drug designation program, as stipulated in the Connecticut General Statute Chapter 319V, section 17b-274d.
    Committee Members
    Committee Bylaws
    Committee Ethics Statement
    Meeting Schedule
    Meeting Agenda, Minutes and Recommendations
    Meeting Guidelines for Submission or Presentation to Committee

    TOP$ Therapeutic Class Review Schedule

    Legislation Addressing the Preferred Drug List
    Links to Connecticut General Statute Chapter 319V, section 17b-274d. Please refer to the history section of the statute for a listing of amendments.

    You can e-mail or call the PDL coordinator, at 1-571-348-0187 with your questions, comments, or concerns.

    Pharmacy Prior Authorization Program
    The Pharmacy Prior Authorization (PA) program is a state-mandated pharmacy initiative. The Pharmacy Prior Authorization program allows DSS to assure appropriate prescribing and utilization of prescribed medications in a cost effective manner. Click on the link below for further information regarding Pharmacy PA.

    Retrospective Drug Utilization Review Program
    The Omnibus Budget Reconciliation Act of 1990 (OBRA '90) requires state Medicaid programs to conduct a comprehensive Drug Utilization Review program. This does not include Connecticut Medical Assistance clients with third party insurance. The RetroDUR program collects and analyzes claims data against predetermined, DUR Board approved criteria to identify and correct aberrant prescribing practices, client misuse, and provider fraud. The RetroDUR program also has functionality to identify potential pharmacy restriction candidates and to specify a pharmacy and/or physician provider to assist in correcting client abuse or misuse. The DUR Board is required to implement corrective action to modify practices via appropriate interventions and demonstrate cost savings.

    Concurrent with RetroDUR and using the resulting data, the DUR contractor also conducts a pharmacy restriction program. Through RetroDUR, provider, and the medical audit division’s input the contractor identifies certain clients who demonstrate the potential to abuse or misuse of prescription drugs. These clients are offered the opportunity to change their behavior and demonstrate appropriate use of prescription drugs. If the clients continue inappropriate behavior, they are restricted to the use of a single pharmacy for a one-year period per Connecticut State law.

    Clients and providers with questions should contact Acentra Health concerning the RetroDUR program operations or pharmacy restriction by calling toll-free to 1-877-719-3123 or by fax to 1-866-743-9788. Further information about the RetroDUR program is available through the following links:

    Blank Spacer
    Home Home    Site Map    About Us    Feedback